Pfizer bought G...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Global Blood Therapeutics
Pfizer bought Global Blood Therapeutics
10/5/22 at 16:56
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.
Global Blood Therapeutics
Review
Source:
investors.pfizer.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Zvezda reported for 3 months of 2024 by RAS
5/3/24
ZVEZ
VK acquired 40% of Intickets.ru ticketing platform
5/3/24
VKCO
Samaraenergo reported for 3 months of 2024 by RAS
5/3/24
SAGO
Samaraenergo reported for 2023 by IFRS
5/3/24
SAGO
Sovcombank's shareholders approved an additional share issue for the purchase of Home Bank
5/3/24
SVCB
EL5-Energo reported for 3 months of 2024 by RAS
5/3/24
ELFV
INARCTICA reported for 3 months of 2024 by RAS
5/3/24
AQUA
Sovcombank reported for 3 months of 2024 by RAS
5/3/24
SVCB
Arsagera reported for 3 months of 2023 by RAS
5/3/24
ARSA
Artgen reported for 3 months of 2024 by RAS
5/3/24
ABIO
«
Previous
209
210
211
212
213
214
215
216
217
218
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)
investors.pfizer.com investors.pfizer.com investors.pfizer.com
English (US) 